✦ LIBER ✦

2.P.59 Efficacy and safety of cerivastatin, a novel potent HMG-CoA reductase inhibitor, in primary hypercholesterolaemia: A comparative study

✍ Scribed by L.A. Leiter

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of 0.8 mg dosage of

✍ Stein, E.; Isaacsohn, J.; Stoltz, R.; Mazzu, A.; Liu, M.-C.; Lane, C.; Heller, A 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 156 KB

In vitro antitumor activity of cerivasta

✍ Wojciech Feleszko; Izabela Mlynarczuk; Dominika Nowis 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Efficacy and safety of a new HMG-CoA red

✍ J Sasaki; Y Ikeda; K Yamamoto; M Ageta; K Arakawa 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 134 KB

In vitro comparative inhibition profiles

✍ C. Transon; T. Leemann; P. Dayer 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 343 KB

Efficacy and safety of monotherapy with

✍ Kaku, Kohei; Watada, Hirotaka; Iwamoto, Yasuhiko; Utsunomiya, Kazunori; Terauchi 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 316 KB